InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
56%
T+90 mean return
-2.5%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Mosca Alison, Director. Insider active across 1 company, notably Clene Inc.. In total, 12 filings have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €3.4m. Activity tracked since 24 May 2021. The latest transaction was disclosed on 9 January 2026 (J). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
57,219 shares0Common StockSEC:0001104659-26-003464:0
16,667 shares@ US$6.002.1% of flowCommon StockSEC:0001104659-26-003464:1
159,134 shares@ US$4.58815.9% of flowCommon StockSEC:0001104659-24-105443:0
2,394,375 shares@ US$0.8042.3% of flowCommon StockSEC:0001562180-23-005323:0
Ideal exit: 12 Mar 2024 (T+270)
792,079 shares@ US$1.0119.6% of flowCommon StockSEC:0001562180-22-007455:0
Ideal exit: 30 Jul 2023 (T+270)
5,000 shares@ US$2.620.020% mcap1.5% of flowCommon StockSEC:0001562180-22-005129:0
Ideal exit: 12 Mar 2023 (T+270)
15,000 shares@ US$0.010.0002% mcap0.0% of flowCommon StockSEC:0001596771-22-000001
15,000 shares@ US$0.010.0002% mcap0.0% of flowCommon StockSEC:0001596771-22-000001:0
2,083 shares0Common StockSEC:0001562180-21-004956
2,083 shares0Common StockSEC:0001562180-21-004956:0
51,921 shares@ US$9.6349.2% of flowCommon StockSEC:0001562180-21-003709
Ideal exit: 18 Feb 2022 (T+270)
51,921 shares@ US$9.630.64% mcap49.2% of flowCommon StockSEC:0001562180-21-003709:0
Ideal exit: 18 Feb 2022 (T+270)
12 of 12 declarations
About Mosca Alison
Alison Mosca is a Board Member at Clene Inc. She is involved in overseeing the company's activities and in strategic decision-making. Her role on the board allows her to provide valuable insights into governance and performance issues. Alison helps ensure that decisions made are aligned with Clene's strategic objectives.
